Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

TIMOLOL MALEATE

TIMOLOL MALEATE

Standard Dose
EQ 0.25% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TIMOLOL MALEATE is listed in Drugs@FDA under application 216343 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TIMOLOL MALEATE Form and strength SOLUTION, GEL FORMING/DROPS;OPHTHALMIC - EQ 0.25% BASE Sponsor AMNEAL Submission history Latest submission status date: 2025-05-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview TIMOLOL MALEATE is listed in Drugs@FDA under application 216343 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TIMOLOL MALEATE Form and strength SOLUTION, GEL FORMING/DROPS;OPHTHALMIC - EQ 0.25% BASE Sponsor AMNEAL Submission history Latest submission status date: 2025-05-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.